HOME › DRUGS › COVID-19 MRNA VACCINE
ACTIVE SUBSTANCE / INN

COVID-19 MRNA VACCINE

Brand name(s): mNexspike, Comirnaty, CureVac’s COVID-19 vaccine (CVnCoV), Spikevax (previously COVID-19 Vaccine Moderna)
EMA LISTED
WITHDRAWN FROM ROLLING REVIEW
AUTHORISED
COVID-19 virus infection
ACTIVE SUBSTANCE
Covid-19 Mrna Vaccine
REGULATORS
EMA
SPONSORS / MAH
CureVac AG, Moderna Biotech Spain, S.L., BioNTech Manufacturing GmbH
TOTAL APPLICATIONS
4
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ComirnatyBioNTech Manufacturing GmbHAuthorised21/12/2020COVID-19 virus infection
mNexspikeModerna Biotech Spain, S.L.Authorised12/02/2026COVID-19 virus infection
Spikevax (previously COVID-19 Vaccine Moderna)Moderna Biotech Spain, S.L.Authorised06/01/2021COVID-19 virus infection
CureVac’s COVID-19 vaccine (CVnCoV)CureVac AGWithdrawn from rolling review—

FULL INTELLIGENCE ON COVID-19 MRNA VACCINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →